Influence of TCF7L2 gene variants on the therapeutic response to the dipeptidylpeptidase-4 inhibitor linagliptin

AIMS/HYPOTHESIS: Individuals carrying variants of the transcription factor 7-like 2 gene (TCF7L2) are at increased risk for type 2 diabetes. These metabolic genetic risk factors have been linked to diminished pancreatic islet-cell responsiveness to incretins, thus pharmacological interventions aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimdahl, Heike, Ittrich, Carina, Graefe-Mody, Ulrike, Boehm, Bernhard O., Mark, Michael, Woerle, Hans-Juergen, Dugi, Klaus A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119242/
https://www.ncbi.nlm.nih.gov/pubmed/24906949
http://dx.doi.org/10.1007/s00125-014-3276-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119242/
https://www.ncbi.nlm.nih.gov/pubmed/24906949
http://dx.doi.org/10.1007/s00125-014-3276-y

Ejemplares similares